首页> 外文期刊>FEBS Open Bio >Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation
【24h】

Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activation

机译:IL13RA2的沉默通过ERK信号通路激活促进肝细胞癌中的部分上皮 - 间充质转变

获取原文
获取外文期刊封面目录资料

摘要

Lack of insight into the mechanisms underlying hepatocellular carcinoma (HCC) metastasis has hindered the development of curative treatments. Overexpression of interleukin‐13 receptor alpha 2 (IL13RA2) has been reported to contribute to invasion and metastasis in several tumors. However, the role of IL13RA2 in HCC remains to be characterized. In this study, we identified that low expression of IL13RA2 is associated with poor survival of patients with HCC, and demonstrated that IL13RA2 knockdown endows HCC cells with invasive potential. Mechanistically, silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition via increasing extracellular signal‐regulated kinase phosphorylation in HCC. Collectively, our results suggest that IL13RA2 may have potential as a prognostic biomarker for HCC.
机译:对肝细胞癌(HCC)转移的潜在机制缺乏了解阻碍了治疗方法的发展。据报道,白细胞介素-13受体α2(IL13RA2)的过度表达有助于在几种肿瘤中侵袭和转移。但是,IL13RA2在HCC中的作用仍有特征。在这项研究中,我们发现IL13RA2的低表达与HCC患者的差,并证明IL13RA2敲低赋予HCC细胞具有侵入性潜力。机械地,IL13RA2的沉默通过增加HCC中的细胞外信号调节激酶磷酸化促进部分上皮 - 间充质转化。统称,我们的结果表明IL13RA2可能具有作为HCC的预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号